Sera Prognostics, Inc. Class A Common Stock (SERA) is a publicly traded Healthcare sector company. As of August 24, 2026, SERA trades at $2.18 with a market cap of $84.42M and a P/E ratio of -3.25. SERA moved -0.93% today. Year to date, SERA is -26.10%; over the trailing twelve months it is -8.40%. Its 52-week range spans $1.37 to $8.73. Analyst consensus is strong buy with an average price target of $6.00. Rallies surfaces SERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SERA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SERA recently traded at $2.18. Market cap is $84.42M. P/E ratio is -3.25. Revenue is $70.00K.
| Metric | Value |
|---|---|
| Price | $2.18 |
| Market Cap | $84.42M |
| P/E Ratio | -3.25 |
| EPS | $-0.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.73 |
| 52-Week Low | $1.37 |
| Volume | 19.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $70.00K |
| Net Income | $-33.23M |
| Gross Margin | -150.00% |
3 analysts cover SERA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.00.